Sumitomo Dainippon Pharma has announced that it will open an office for regenerative cell medicine in San Diego, California. The office will be used for promoting drug development and gathering technological information in the United States. It will give the company a foothold for developing in the U.S. a market for regenerative cell medicine, which the company positions as a growth field. San Diego is home to the research centers of many bio-related startups and major pharmaceutical companies. The company chose to set up the office in San Diego as it is a suitable location for gathering information. (Abridged)